Companies are spending 93% of their AI budgets on tech and only 7% on people. It's already backfiring.

You've decided to give the World Cup a watch, just to see what the rest of the planet is so mad for. Even if you played ...

Excerpted with permission from AI for the Rest of Us: An Illustrated Introduction, Sairam Sundaresan, Bloomsbury India.

Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously untreated ...

High-value assets including domain controllers, web servers, and identity infrastructure are frequent targets in ...

A day after Tehran dismissed U.S. President Donald Trump’s 15-point ceasefire plan, the American leader claimed that Iran was ...

B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) ("B2Gold" or the "Company") is pleased to announce positive exploration ...